Healthcare Professional and Patient Surveys to Assess the Effectiveness of Risk Minimization Measures for Concentrated Insulin Lispro (Humalog 200 units/mL KwikPen) (F3Z-MC-B020)

16/08/2016
18/08/2017
EU PAS number:
EUPAS14789
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

F3Z-MC-B020_EU-PAS-Registered

English (303.88 KB - PDF) View document
Study results
Study report
Other information